The Frequency of Synchronous Parathyroid Adenomas and Papillary Thyroid Carcinomas: Clinicopathological Evaluation
Yıl: 2022 Cilt: 26 Sayı: 4 Sayfa Aralığı: 197 - 202 Metin Dili: İngilizce DOI: 10.5152/tjem.2022.22062 İndeks Tarihi: 13-05-2023
The Frequency of Synchronous Parathyroid Adenomas and Papillary Thyroid Carcinomas: Clinicopathological Evaluation
Öz: Objective: We aimed to evaluate the frequency and clinicopathological features of papillary thyroid carcinomas synchronized with parathyroid adenoma and to compare the “parathyroid adenoma with papillary thyroid carcinoma” and “parathyroid adenoma without papillary thyroid carcinoma” groups. Methods: The study included 287 parathyroid adenoma cases that had concomitant thyroid surgery. Age, gender, parathyroid adenoma characteristics, diagnosis for thyroid materials, and clinicopatho logical prognostic parameters for papillary thyroid carcinomas were recorded from the pathology reports. Results: Synchronous parathyroid adenoma and thyroid malignancy rate was 27.2%, and papillary thyroid carcinomas were 88.5% of the malignancies. Papillary thyroid carcinomas were mostly seen in female patients and in right thyroid lobe, the multifocality rate was 18.8%, the follicular variant being the most common, the majority were papillary microcarcinomas and pT1 tumors, extrathyroi dal extension rate was 13%. “Parathyroid adenoma with papillary thyroid carcinoma” and “parathyroid adenoma without papillary thyroid carcinoma” groups were statistically similar in the patient and parathyroid adenoma characteristics. Intrathyroidal parathyroid adenomas and the right parathyroid gland involvement were more common in “parathyroid adenoma with papillary thyroid carcinoma” group, while multiple parathyroid adenomas and left parathyroid gland involvement were more common in “parathyroid adenoma without papillary thyroid carcinoma” group. Inferior parathyroid gland involvement was more common than the superior, and the mean parathyroid adenoma size was similar for both groups. Conclusion: Synchronous parathyroid adenoma and papillary thyroid carcinoma cases are not uncommon, and detection of papillary thyroid carcinoma may change the surgical procedure. Therefore, all parathyroid adenoma cases should be thoroughly investigated for concomitant thyroid pathologies before surgery. Keywords: Papillary thyroid ca
Anahtar Kelime: Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- 1. Jeong C, Kwon HI, Baek H, et al. Association of hyperparathyroidism and papillary thyroid cancer: a multicenter retrospective study. Endocrinol Metab (Seoul). 2020;35(4):925-932. [CrossRef]
- 2. Çetin K, Sıkar HE, Temizkan Ş, et al. Does primary hyperparathyroidism have an association with thyroid papillary cancer? A retrospective cohort study. World J Surg. 2019;43(5):1243-1248. [CrossRef]
- 3. Wang B, Xu X, Zhao ZY, Yan JB, Yao DY. A rare coexistence of parathyroid adenoma and medullary and papillary thyroid carcinoma. Int J Clin Exp Pathol. 2020;13(9):2387-2391.
- 4. Emirikçi S, Özçınar B, Öner G, et al. Thyroid cancer incidence in simultane ous thyroidectomy with parathyroid surgery. Ulus Cerrahi Derg. 2015;31(4):214-217. [CrossRef]
- 5. Beebeejaun M, Chinnasamy E, Wilson P, Sharma A, Beharry N, Bano G. Papillary carcinoma of the thyroid in patients with primary hyperparathyroidism: is there a link? Med Hypo. 2017;103:100-104. [CrossRef]
- 6. Li L, Li B, Lv B, et al. Increased thyroid malignancy in patients with pri mary hyperparathyroidism. Endocr Connect. 2021;10(8):885-893. [CrossRef]
- 7. Kutlutürk K, Otan E, Yağcı MA, Usta S, Aydın C, Ünal B. Thyroid patholo gies accompanying primary hyperparathyroidism: a high rate of papil lary thyroid microcarcinoma. Ulus Cerrahi Derg. 2014;30(3):125-128. [CrossRef]
- 8. Kösem M, Algün E, Kotan C, Harman M, Oztürk M. Coexistent thyroid pathologies and high rate of papillary cancer in patients with primary hyperparathyroidism: controversies about minimal invasive parathyroid surgery. Acta Chir Belg. 2004;104(5):568-571. [CrossRef]
- 9. Gündeş E, Çakır M, Aksoy F, Küçükkartallar T, Taşcı Hİ. Coexistence of parathyroid adenoma and papillary thyroid carcinoma: experience of a single center. Dicle Med J. 2013;40(2):237-240. [CrossRef]
- 10. Yazici P, Mihmanli M, Bozdag E, Aygun N, Uludag M. Incidental finding of papillary thyroid carcinoma in the patients with primary hyperpar athyroidism. Eurasian J Med. 2015;47(3):194-198. [CrossRef]
- 11. Lehwald N, Cupisti K, Krausch M, Ahrazoglu M, Raffel A, Knoefel WT. Coin cidence of primary hyperparathyroidism and nonmedullary thyroid car cinoma. Horm Metab Res. 2013;45(9):660-663. [CrossRef]
- 12. Gul K, Ozdemir D, Korukluoglu B, et al. Preoperative and postoperative evaluation of thyroid disease in patients undergoing surgical treatment of primary hyperparathyroidism. Endocr Pract. 2010;16(1):7-13. [CrossRef]
- 13. Lyold RV, Osamura RY, Klöppel G, Rosai J, eds. WHO Classification of Tumours of Endocrine Organs. 4th ed. Lyon, France: IARC; 2017.
- 14. Tuttle RM, Morris LF, Haugen BR, et al. Thyroid - differentiated and ana plastic carcinoma. In: Amin MB, Edge SB, Greene FL, et al., eds. AJCC Cancer Staging Manual. 8th ed. Switzerland: Springer International Pub lishing AG; 2017:873-890.
- 15. Celik M, Guldiken S, Ayturk S, et al. Benign and malignant thyroid gland diseases in the patients with primary hyperparathyroidism. Int J Appl Basic Med Res. 2017;7(2):117-120. [CrossRef]
- 16. Liu Y, Guo S, Sang S, et al. Differences in clinicopathological characteris tics of papillary thyroid carcinoma between symptomatic and asympto matic patients with primary hyperparathyroidism. Int J Endocrinol. 2021;2021:9917694. [CrossRef]
- 17. Özden S, Saylam B, Daglar G, Yuksek YN, Tez M. Are thyroid nodules an obstacle to minimal invasive parathyroid surgery? A single-center study from an endemic goiter region. Acta Endocrinol (Buchar). 2019;15(4):531- 536. [CrossRef]
- 18. Tsai CY, Chen ST, Hsueh C, Lin YS, Lin JD. Long-term therapeutic out comes of papillary thyroid carcinoma with concomitant hyperparathy roidism: a single center case-control study. Biomed J. 2020;43(1):53-61. [CrossRef]
APA | demir h, Kutlu Ö, Yol C, Gülle B, Ozturk T (2022). The Frequency of Synchronous Parathyroid Adenomas and Papillary Thyroid Carcinomas: Clinicopathological Evaluation. , 197 - 202. 10.5152/tjem.2022.22062 |
Chicago | demir hale,Kutlu Özce,Yol Cansu,Gülle Buğra Taygun,Ozturk Tulin The Frequency of Synchronous Parathyroid Adenomas and Papillary Thyroid Carcinomas: Clinicopathological Evaluation. (2022): 197 - 202. 10.5152/tjem.2022.22062 |
MLA | demir hale,Kutlu Özce,Yol Cansu,Gülle Buğra Taygun,Ozturk Tulin The Frequency of Synchronous Parathyroid Adenomas and Papillary Thyroid Carcinomas: Clinicopathological Evaluation. , 2022, ss.197 - 202. 10.5152/tjem.2022.22062 |
AMA | demir h,Kutlu Ö,Yol C,Gülle B,Ozturk T The Frequency of Synchronous Parathyroid Adenomas and Papillary Thyroid Carcinomas: Clinicopathological Evaluation. . 2022; 197 - 202. 10.5152/tjem.2022.22062 |
Vancouver | demir h,Kutlu Ö,Yol C,Gülle B,Ozturk T The Frequency of Synchronous Parathyroid Adenomas and Papillary Thyroid Carcinomas: Clinicopathological Evaluation. . 2022; 197 - 202. 10.5152/tjem.2022.22062 |
IEEE | demir h,Kutlu Ö,Yol C,Gülle B,Ozturk T "The Frequency of Synchronous Parathyroid Adenomas and Papillary Thyroid Carcinomas: Clinicopathological Evaluation." , ss.197 - 202, 2022. 10.5152/tjem.2022.22062 |
ISNAD | demir, hale vd. "The Frequency of Synchronous Parathyroid Adenomas and Papillary Thyroid Carcinomas: Clinicopathological Evaluation". (2022), 197-202. https://doi.org/10.5152/tjem.2022.22062 |
APA | demir h, Kutlu Ö, Yol C, Gülle B, Ozturk T (2022). The Frequency of Synchronous Parathyroid Adenomas and Papillary Thyroid Carcinomas: Clinicopathological Evaluation. Turkish Journal of Endocrinology and Metabolism, 26(4), 197 - 202. 10.5152/tjem.2022.22062 |
Chicago | demir hale,Kutlu Özce,Yol Cansu,Gülle Buğra Taygun,Ozturk Tulin The Frequency of Synchronous Parathyroid Adenomas and Papillary Thyroid Carcinomas: Clinicopathological Evaluation. Turkish Journal of Endocrinology and Metabolism 26, no.4 (2022): 197 - 202. 10.5152/tjem.2022.22062 |
MLA | demir hale,Kutlu Özce,Yol Cansu,Gülle Buğra Taygun,Ozturk Tulin The Frequency of Synchronous Parathyroid Adenomas and Papillary Thyroid Carcinomas: Clinicopathological Evaluation. Turkish Journal of Endocrinology and Metabolism, vol.26, no.4, 2022, ss.197 - 202. 10.5152/tjem.2022.22062 |
AMA | demir h,Kutlu Ö,Yol C,Gülle B,Ozturk T The Frequency of Synchronous Parathyroid Adenomas and Papillary Thyroid Carcinomas: Clinicopathological Evaluation. Turkish Journal of Endocrinology and Metabolism. 2022; 26(4): 197 - 202. 10.5152/tjem.2022.22062 |
Vancouver | demir h,Kutlu Ö,Yol C,Gülle B,Ozturk T The Frequency of Synchronous Parathyroid Adenomas and Papillary Thyroid Carcinomas: Clinicopathological Evaluation. Turkish Journal of Endocrinology and Metabolism. 2022; 26(4): 197 - 202. 10.5152/tjem.2022.22062 |
IEEE | demir h,Kutlu Ö,Yol C,Gülle B,Ozturk T "The Frequency of Synchronous Parathyroid Adenomas and Papillary Thyroid Carcinomas: Clinicopathological Evaluation." Turkish Journal of Endocrinology and Metabolism, 26, ss.197 - 202, 2022. 10.5152/tjem.2022.22062 |
ISNAD | demir, hale vd. "The Frequency of Synchronous Parathyroid Adenomas and Papillary Thyroid Carcinomas: Clinicopathological Evaluation". Turkish Journal of Endocrinology and Metabolism 26/4 (2022), 197-202. https://doi.org/10.5152/tjem.2022.22062 |